Lite Strategy, Inc.LITS

$0.83-0.09 (-9.94%)

NASDAQFinancial Services24:00 UTC

Company snapshot

Market Cap

$6M

Micro-cap

-79%

2025 — today

10-Year Price

-79%

2025 — today

52-Week Range

$0.73$4.53

Current $0.83· 2%

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Valuation in context

P/E ratio

-0.1

N/A

Not meaningful — company is unprofitable

P/B ratio

0.1

Below average

Below the 10-year average

FCF Yield

-188.9%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when LITS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.